Clinical trial
A Study on Efficacy (Effectiveness), Safety, and Impact on Quality of Life…
NCT00398788 · Alza Corporation, DE, USA, Industry · Completed
Key facts
| NCT number | NCT00398788 |
|---|---|
| Title | A Study on Efficacy (Effectiveness), Safety, and Impact on Quality of Life Measures of Dilaudid CR (Controlled Release);, Hydromorphone HCl in Patients With Chronic Low Back Pain |
| Official title | An Open-Label, Repeated-Dose Trial to Characterize the Efficacy and Safety, and Impact on Quality of Life Measures of Dilaudid CR (Hydromorphone HCI) in Patients With Chronic Low Back Pain |
| Lead sponsor | Alza Corporation, DE, USA, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Low Back Pain |
| Intervention type | Drug |
| Interventions | OROS® hydromorphone HCL, Dilaudid CR (controlled release), Dilaudid IR (immediate release) as rescue medicine |
| Enrollment | 207 |
| Completion | Nov 1, 2001 |
| First posted | Nov 14, 2006 |
| Last update posted | Apr 27, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: